IARRX
Price
$16.50
Change
-$0.17 (-1.02%)
Updated
Aug 8 closing price
Net Assets
713.66M
VGSIX
Price
$29.57
Change
-$0.26 (-0.87%)
Updated
Aug 8 closing price
Net Assets
63.72B
Interact to see
Advertisement

IARRX vs VGSIX

Header iconIARRX vs VGSIX Comparison
Open Charts IARRX vs VGSIXBanner chart's image
Invesco Real Estate R
Price$16.50
Change-$0.17 (-1.02%)
VolumeN/A
Net Assets713.66M
Vanguard Real Estate Index Investor
Price$29.57
Change-$0.26 (-0.87%)
VolumeN/A
Net Assets63.72B
IARRX vs VGSIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IARRX vs. VGSIX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IARRX is a Buy and VGSIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSIX has more cash in the bank: 63.7B vs. IARRX (714M). VGSIX pays higher dividends than IARRX: VGSIX (3.74) vs IARRX (1.89). IARRX was incepted earlier than VGSIX: IARRX (21 years) vs VGSIX (29 years). IARRX (1.63) is less costly to investors than VGSIX (0.27). IARRX is a more actively managed with annual turnover of: 63.00 vs. VGSIX (7.00). VGSIX has a lower initial minimum investment than IARRX: VGSIX (0) vs IARRX (1000). VGSIX annual gain was more profitable for investors over the last year : 2.64 vs. IARRX (-4.04). VGSIX return over 5 years is better than : 30.82 vs. IARRX (-2.83).
IARRXVGSIXIARRX / VGSIX
Total Expense Ratio1.630.27604%
Annual Report Gross Expense Ratio1.630.27604%
Fund Existence21 years29 years-
Gain YTD-0.3492.649-13%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets714M63.7B1%
Annual Yield % from dividends1.893.7451%
Returns for 1 year-4.042.64-153%
Returns for 3 years-17.482.73-640%
Returns for 5 years-2.8330.82-9%
Returns for 10 years-27.7558.22-48%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATRA10.95N/A
-0.05%
Atara Biotherapeutics Inc.
SSD181.31-0.72
-0.40%
Simpson Manufacturing Co
BEAM17.62-0.24
-1.34%
Beam Therapeutics
RCEL4.25-1.13
-21.00%
Avita Medical